Arch Therapeutics plans clinical trials of a nanostructured fluid that stops bleeding almost instantly by transforming into a gel in the presence of blood.

Eventually, the material could be used by first responders to stop bleeding at accident sites and on the battlefield.

The material, a synthetic peptide, was discovered at MIT in the early 1990s.